Skip To Main Content
Určeno pro odbornou veřejnost
Campus
Campus
View Full Results

Transplantační medicína

Nejnovější trendy

Prozkoumejte nejčtenější články a videa na Campus Sanofi

Seřadit
Why compromise for less: Should PCSK9 inhibitors be initial therapy?

Why compromise for less: Should PCSK9 inhibitors be initial therapy?

Číst více
Why compromise for less: Should PCSK9 inhibitors be initial therapy?

Why compromise for less: Should PCSK9 inhibitors be initial therapy?

Číst více
Odyssey Outcomes - Total Events Analysis

Odyssey Outcomes - Total Events Analysis

Číst více
Odyssey Outcomes - Total Events Analysis

Odyssey Outcomes - Total Events Analysis

Číst více
Odyssey Outcomes - Total Events Analysis

Odyssey Outcomes - Total Events Analysis

Číst více
Odyssey Outcomes - Total Events Analysis

Odyssey Outcomes - Total Events Analysis

Číst více
Ticagrelor vs Clopidogrel in high bleeding risk patients with ACS

Ticagrelor vs Clopidogrel in high bleeding risk patients with ACS

Číst více
Odyssey outcomes - CVOT mortality sub-analysis

Odyssey outcomes - CVOT mortality sub-analysis

Číst více
Odyssey outcomes - CVOT mortality sub-analysis

Odyssey outcomes - CVOT mortality sub-analysis

Číst více
Odyssey outcomes - CVOT mortality sub-analysis

Odyssey outcomes - CVOT mortality sub-analysis

Číst více
Odyssey outcomes - CVOT mortality sub-analysis

Odyssey outcomes - CVOT mortality sub-analysis

Číst více
LLTs Exposure Time and Major Vascular Risk Reduction

LLTs Exposure Time and Major Vascular Risk Reduction

Číst více